Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.

Sivaprasad, S; Prevost, AT; Vasconcelos, JC; Riddell, A; Murphy, C; Kelly, J; Bainbridge, J; Sivaprasad, S; Prevost, AT; Vasconcelos, JC; Riddell, A; Murphy, C; Kelly, J; Bainbridge, J; Tudor-Edwards, R; Hopkins, D; Hykin, P; CLARITY Study Group, ; - view fewer (2017) Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Lancet 10.1016/S0140-6736(17)31193-5 .

http://ift.tt/2qGSoYc